At the news
? BULLISHIMPACT 6/10 8-K filed Apr 13, 2026 at 16:10 ET
Sana Biotechnology entered into a stock purchase agreement with Mayo Clinic, selling 7.5 million shares for $25 million upfront, with an option for Mayo Clinic to purchase an additional 7.5 million shares for another $25 million. The proceeds will be used for developing diabetes therapies, and Mayo Clinic agreed to a six-month lock-up period.
- Sana Biotechnology sold 7,507,507 shares to Mayo Clinic for $24.999 million at $3.33 per share
- Mayo Clinic has the option to purchase an additional 7,507,507 shares for $24.999 million
- Proceeds will be used for developing products including SC451 and genetically modified stem-cell derived islet cell products
- Mayo Clinic agreed to a lock-up period of six months from the initial closing
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access